antihypertensives_upd
TRANSCRIPT
-
8/8/2019 Antihypertensives_upd
1/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Drugs AffectingDrugs AffectingBlood PressureBlood Pressure
-
8/8/2019 Antihypertensives_upd
2/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Blood Pressure ControlBlood Pressure ControlElementsElements
Heart RateHeart Rate
Stroke VolumeStroke Volume
Peripheral Vascular Peripheral Vascular ResistanceResistance
-
8/8/2019 Antihypertensives_upd
3/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Blood Pressure ControlBlood Pressure ControlBaroreceptorsBaroreceptors
ReninRenin--Angiotensin System Angiotensin System
-
8/8/2019 Antihypertensives_upd
4/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
HypertensionHypertensionHigh blood pressureHigh blood pressure
Normal:Normal: Systolic < 130 mmHgSystolic < 130 mmHg
Diastolic < 85 mm HgDiastolic < 85 mm Hg
-
8/8/2019 Antihypertensives_upd
5/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Classification of Blood PressureClassification of Blood Pressure
CategoryCategory Systemic BP (mm Hg)Systemic BP (mm Hg) Diastolic BP (mm Hg)Diastolic BP (mm Hg)
NormalNormal
-
8/8/2019 Antihypertensives_upd
6/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Classification of Blood PressureClassification of Blood Pressure
Primary HypertensionPrimary Hypertension
Specific cause unknownSpecific cause unknown
90% of the cases90% of the casesAlso known as essential or idiopathic hypertension Also known as essential or idiopathic hypertension
Secondary HypertensionSecondary Hypertension
Cause is known (such as eclampsia of pregnancy,Cause is known (such as eclampsia of pregnancy,renal artery disease, pheochromocytoma)renal artery disease, pheochromocytoma)
10% of the cases10% of the cases
-
8/8/2019 Antihypertensives_upd
7/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
SteppedStepped- -Care Management of HPNCare Management of HPNby JNC 7by JNC 7Step 1: Lifestyle modificationStep 1: Lifestyle modification
weight reductionweight reduction
reductionreductionmoderation of alcohol intakemoderation of alcohol intake
smoking cessationsmoking cessation
physical activity increasephysical activity increase
-
8/8/2019 Antihypertensives_upd
8/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
SteppedStepped- -Care Management of HPNCare Management of HPNby JNC 7by JNC 7Step 2 : Inadequate ResponseStep 2 : Inadequate Response
continue lifestyle modificationcontinue lifestyle modification
initial drug selectioninitial drug selection
1. Diuretic or Beta blocker 1. Diuretic or Beta blocker
2. ACE inhibitor, calcium channel2. ACE inhibitor, calcium channelblocker, ARBblocker, ARB
-
8/8/2019 Antihypertensives_upd
9/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
SteppedStepped- -Care Management of HPNCare Management of HPNby JNC 7by JNC 7Step 3 : Inadequate ResponseStep 3 : Inadequate Response
increase drug dose, or increase drug dose, or
substitute another drug, or substitute another drug, or
add a 2add a 2 ndnd drug from another classdrug from another class
-
8/8/2019 Antihypertensives_upd
10/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
SteppedStepped- -Care Management of HPNCare Management of HPNby JNC 7by JNC 7Step 4 : Inadequate ResponseStep 4 : Inadequate Response
add a 2add a 2 ndnd or 3or 3 rdrd agent or diuretic if notagent or diuretic if notalready prescribedalready prescribed
-
8/8/2019 Antihypertensives_upd
11/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
HypotensionHypotension
Hypotensive states:Hypotensive states:
Heart muscle is damagedHeart muscle is damaged
-
8/8/2019 Antihypertensives_upd
12/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Blood Pressure = COBlood Pressure = CO x x SVRSVR
CO = Cardiac outputCO = Cardiac output
SVR = Systemic vascular resistanceSVR = Systemic vascular resistance
-
8/8/2019 Antihypertensives_upd
13/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Instructors may want to insertInstructors may want to insertEIC Image #69:EIC Image #69:
Blood Pressure: Normal RegulationBlood Pressure: Normal Regulation
-
8/8/2019 Antihypertensives_upd
14/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents Antihypertensive Agents
Medications used to treat hypertensionMedications used to treat hypertension
-
8/8/2019 Antihypertensives_upd
15/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Ag ents:Antihypertensive Ag ents:
Cate g oriesCate g oriesSympathetic Nervous SystemSympathetic Nervous SystemBlockers/Adrenergic agentsBlockers/Adrenergic agents
Angiotensin Angiotensin- -converting enzyme inhibitorsconverting enzyme inhibitorsAngiotensin II receptor blockers Angiotensin II receptor blockers
Calcium channel blockersCalcium channel blockers
DiureticsDiuretics
VasodilatorsVasodilators
-
8/8/2019 Antihypertensives_upd
16/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Categories Antihypertensive Agents: Categories
Sympathetic Nervous System Blockers/ Adrenergic agents
Alpha1 blockers Alpha1 blockers
Beta blockers (cardioselective and nonselective)Beta blockers (cardioselective and nonselective)
Centrally acting alpha blockersCentrally acting alpha blockers
Combined alphaCombined alpha- -beta blockersbeta blockers
PeripheralPeripheral- -acting adrenergic agentsacting adrenergic agents
-
8/8/2019 Antihypertensives_upd
17/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Mechanism of ActionMechanism of ActionAdrener g ic Ag entsAdrener g ic Ag ents
Alpha1 Blockers Alpha1 Blockers (peripherally acting)(peripherally acting)Block the alpha1Block the alpha1- -adrenergic receptorsadrenergic receptorsThe SNS is not stimulatedThe SNS is not stimulated
Result: DECREASED blood pressureResult: DECREASED blood pressure
Stimulation of alpha1Stimulation of alpha1- -adrenergic receptorsadrenergic receptorscauses HYPERtensioncauses HYPERtensionBlocking alpha1Blocking alpha1- -adrenergic receptors causes decreasedadrenergic receptors causes decreasedblood pressureblood pressure
-
8/8/2019 Antihypertensives_upd
18/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Adrenergic Agents Adrenergic Agents
Alpha1 Blockers Alpha1 Blockers
doxazosin (Cardura)doxazosin (Cardura)
prazosin (Minipress)prazosin (Minipress)
terazosin (Hytrin)terazosin (Hytrin)
-
8/8/2019 Antihypertensives_upd
19/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Mechanism of ActionMechanism of Action Adrenergic Agents Adrenergic Agents
CentralCentral- -Acting Adrenergics Acting Adrenergics
Stimulate alpha2Stimulate alpha2- -adrenergic receptorsadrenergic receptors
Sympathetic outflow from the CNS is decreasedSympathetic outflow from the CNS is decreased
Result: decreased blood pressureResult: decreased blood pressure
-
8/8/2019 Antihypertensives_upd
20/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Adrenergic Agents Adrenergic Agents
CentralCentral- -Acting Adrenergics Acting Adrenergics
clonidine (Catapres)clonidine (Catapres)
methyldopa (Aldomet)methyldopa (Aldomet)(drug of choice for hypertension in pregnancy)(drug of choice for hypertension in pregnancy)
-
8/8/2019 Antihypertensives_upd
21/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Mechanism of ActionMechanism of Action Adrenergic Agents Adrenergic Agents
Adrenergic Neuronal Blockers Adrenergic Neuronal Blockers(peripherally acting)(peripherally acting)
Inhibit release of norepinephrineInhibit release of norepinephrine
Also deplete norepinephrine stores Also deplete norepinephrine stores
SNS (peripheral adrenergic nerves) is not stimulatedSNS (peripheral adrenergic nerves) is not stimulated
Result: decreased blood pressureResult: decreased blood pressure
-
8/8/2019 Antihypertensives_upd
22/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Adrenergic Agents Adrenergic Agents
Adrenergic Neuronal Blockers Adrenergic Neuronal Blockers(peripherally acting)(peripherally acting)
reserpinereserpine
guanadrel (Hylorel)guanadrel (Hylorel)
guanethidine (Ismelin)guanethidine (Ismelin)
-
8/8/2019 Antihypertensives_upd
23/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents: Adrenergic Agents Adrenergic AgentsTherapeutic UsesTherapeutic Uses
Alpha1 blockers (peripherally acting) Alpha1 blockers (peripherally acting)
Treatment of hypertensionTreatment of hypertension
Relief of symptoms of BPHRelief of symptoms of BPH
Management of of severe CHF when usedManagement of of severe CHF when usedwith cardiac glycosides and diureticswith cardiac glycosides and diuretics
-
8/8/2019 Antihypertensives_upd
24/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Adrenergic Agents Adrenergic AgentsTherapeutic UsesTherapeutic Uses
CentralCentral- -Acting Adrenergics Acting Adrenergics
Treatment of hypertension, either alone or Treatment of hypertension, either alone or with other agentswith other agents Usually used after other agents have failedUsually used after other agents have failed
due to side effectsdue to side effects Also may be used for treatment of severe Also may be used for treatment of severe
dysmenorrhea, menopausal flushing, glaucomadysmenorrhea, menopausal flushing, glaucoma Clonidine is useful in the management of Clonidine is useful in the management of
withdrawal symptoms in opioidwithdrawal symptoms in opioid- - or nicotineor nicotine- -dependent personsdependent persons
-
8/8/2019 Antihypertensives_upd
25/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Adrenergic Agents Adrenergic AgentsTherapeutic UsesTherapeutic Uses
Adrenergic neuronal blockers Adrenergic neuronal blockers(peripherally acting)(peripherally acting)
Treatment of hypertension, either alone or withTreatment of hypertension, either alone or withother agentsother agents
Seldom used because of frequent side effectsSeldom used because of frequent side effects
-
8/8/2019 Antihypertensives_upd
26/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Adrenergic Agents Adrenergic AgentsSide EffectsSide Effects
Most common:Most common: dry mouthdry mouth drowsinessdrowsinesssedationsedation constipationconstipation
Other:Other: headachesheadaches sleep disturbancessleep disturbancesnauseanausea rashrashcardiac disturbances (palpitations)cardiac disturbances (palpitations)
HIGH INCIDENCE OF ORTHOSTATIC HYPOTENSIONHIGH INCIDENCE OF ORTHOSTATIC HYPOTENSION
-
8/8/2019 Antihypertensives_upd
27/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
CategoriesCategories Angiotensin Angiotensin- -Converting Enzyme InhibitorsConverting Enzyme Inhibitors
(ACE Inhibitors)(ACE Inhibitors)
Large group of safe and effective drugsLarge group of safe and effective drugs
Often used as firstOften used as first- -line agents for CHFline agents for CHFand hypertensionand hypertension
May be combined with a thiazide diureticMay be combined with a thiazide diureticor calcium channel blocker or calcium channel blocker
-
8/8/2019 Antihypertensives_upd
28/56
-
8/8/2019 Antihypertensives_upd
29/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Mechanism of ActionMechanism of Action ACE Inhibitors ACE Inhibitors
Aldosterone stimulates water and sodium resorption. Aldosterone stimulates water and sodium resorption.
Result: increased blood volume, increased preload,Result: increased blood volume, increased preload,and increased Band increased B
-
8/8/2019 Antihypertensives_upd
30/56
-
8/8/2019 Antihypertensives_upd
31/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents Antihypertensive Agents ACE Inhibitors ACE Inhibitors
captopril (Capoten)captopril (Capoten)
Short half Short half- -life, must be dosed more frequentlylife, must be dosed more frequentlythan othersthan othersenalapril (Vasotec)enalapril (Vasotec)
The only ACE inhibitor available in oral andThe only ACE inhibitor available in oral andparenteral formsparenteral forms
lisinopril (Prinivil and Zestril) and quinapril (Accupril)lisinopril (Prinivil and Zestril) and quinapril (Accupril)
Newer agents, long half Newer agents, long half- -lives, oncelives, once- -aa--day dosingday dosing
Several other agents availableSeveral other agents available
-
8/8/2019 Antihypertensives_upd
32/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Therapeutic UsesTherapeutic Uses ACE Inhibitors ACE Inhibitors
HypertensionHypertension
CHF (either alone or in combination with diureticsCHF (either alone or in combination with diureticsor other agents)or other agents)
Slows progression of left ventricular hypertrophySlows progression of left ventricular hypertrophy
after an MIafter an MIRenal protective effects in patients with diabetesRenal protective effects in patients with diabetes
Drugs of choice in hypertensive patients with CHFDrugs of choice in hypertensive patients with CHF
-
8/8/2019 Antihypertensives_upd
33/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Side EffectsSide Effects ACE Inhibitors ACE Inhibitors
FatigueFatigue DizzinessDizziness
HeadacheHeadache Mood changesMood changesImpaired tasteImpaired taste
Dry, nonproductive cough, reverses when therapy is stoppedDry, nonproductive cough, reverses when therapy is stopped
NOTE: firstNOTE: first- -dose hypotensive effect may occur!!dose hypotensive effect may occur!!
-
8/8/2019 Antihypertensives_upd
34/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
CategoriesCategories Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers
(A II Blockers or ARBs)(A II Blockers or ARBs)
Newer classNewer class
WellWell--toleratedtolerated
Do not cause coughingDo not cause coughing
-
8/8/2019 Antihypertensives_upd
35/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Mechanism of ActionMechanism of Action Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers
Allow angiotensin I to be converted to angiotensin II, Allow angiotensin I to be converted to angiotensin II,but block the receptors that receive angiotensin IIbut block the receptors that receive angiotensin II
Block vasoconstriction and release of aldosteroneBlock vasoconstriction and release of aldosterone
-
8/8/2019 Antihypertensives_upd
36/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers
losartan (Cozaar)losartan (Cozaar)
eposartan (Teveten)eposartan (Teveten)
valsartan (Diovan)valsartan (Diovan)
irbesartan (Avapro)irbesartan (Avapro)
candesartan (Atacand)candesartan (Atacand)
telmisartan (Micardis)telmisartan (Micardis)
-
8/8/2019 Antihypertensives_upd
37/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Therapeutic UsesTherapeutic Uses Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers
HypertensionHypertension
Adjunctive agents for the treatment of CHF Adjunctive agents for the treatment of CHF
May be used alone or with other agents suchMay be used alone or with other agents suchas diureticsas diuretics
-
8/8/2019 Antihypertensives_upd
38/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Side EffectsSide Effects Angiotensin II Receptor Blockers Angiotensin II Receptor Blockers
Upper respiratory infectionsUpper respiratory infections
HeadacheHeadache
May cause occasional dizziness, inability to sleep,May cause occasional dizziness, inability to sleep,diarrhea, dyspnea, heartburn, nasal congestion,diarrhea, dyspnea, heartburn, nasal congestion,back pain, fatigueback pain, fatigue
-
8/8/2019 Antihypertensives_upd
39/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
CategoriesCategoriesCalcium Channel BlockersCalcium Channel Blockers
BenzothiazepinesBenzothiazepines
DihydropyridinesDihydropyridines
PhenylalkylaminesPhenylalkylamines
-
8/8/2019 Antihypertensives_upd
40/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Mechanism of ActionMechanism of ActionCalcium Channel BlockersCalcium Channel Blockers
Cause smooth muscle relaxation by blocking theCause smooth muscle relaxation by blocking thebinding of calcium to its receptors, preventingbinding of calcium to its receptors, preventingmuscle contractionmuscle contraction
This causes decreased peripheral smooth muscleThis causes decreased peripheral smooth muscletone, decreased systemic vascular resistancetone, decreased systemic vascular resistance
Result: decreased blood pressureResult: decreased blood pressure
-
8/8/2019 Antihypertensives_upd
41/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents Antihypertensive Agents
Calcium Channel BlockersCalcium Channel Blockers
Benzothiazepines:Benzothiazepines:
diltiazem (Cardizem, Dilacor)diltiazem (Cardizem, Dilacor)
Phenylalkamines:Phenylalkamines:
verapamil (Calan, Isoptin)verapamil (Calan, Isoptin)
Dihydropyridines:Dihydropyridines: amlodipine (Norvasc), bepridil (Vascor),amlodipine (Norvasc), bepridil (Vascor),
nicardipine (Cardene)nicardipine (Cardene)
nifedipine (Procardia), nimodipine (Nimotop)nifedipine (Procardia), nimodipine (Nimotop)
-
8/8/2019 Antihypertensives_upd
42/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Therapeutic UsesTherapeutic UsesCalcium Channel BlockersCalcium Channel Blockers
Angina Angina
HypertensionHypertension
DysrhythmiasDysrhythmias
Migraine headachesMigraine headaches
-
8/8/2019 Antihypertensives_upd
43/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Side EffectsSide EffectsCalcium Channel BlockersCalcium Channel Blockers
Cardiovascular Cardiovascular
hypotension, palpitations, tachycardiahypotension, palpitations, tachycardia
GastrointestinalGastrointestinal
constipation, nauseaconstipation, nausea
Other Other
rash, flushing, peripheral edema, dermatitisrash, flushing, peripheral edema, dermatitis
-
8/8/2019 Antihypertensives_upd
44/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Diuretics Antihypertensive Agents: Diuretics
Decrease the plasma and extracellular fluid volumesDecrease the plasma and extracellular fluid volumes
Results:Results: decreased preloaddecreased preload
decreased cardiac outputdecreased cardiac outputdecreased total peripheral resistancedecreased total peripheral resistance
Overall effect:Overall effect: decreased workload of the heart,decreased workload of the heart,and decreased blood pressureand decreased blood pressure
-
8/8/2019 Antihypertensives_upd
45/56
-
8/8/2019 Antihypertensives_upd
46/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents Antihypertensive Agents
VasodilatorsVasodilators
diazoxide (Hyperstat)diazoxide (Hyperstat)
hydralazine HCl (Apresoline)hydralazine HCl (Apresoline)
minoxidil (Loniten, Rogaine)minoxidil (Loniten, Rogaine)
sodium nitroprusside (Nipride, Nitropress)sodium nitroprusside (Nipride, Nitropress)
-
8/8/2019 Antihypertensives_upd
47/56
-
8/8/2019 Antihypertensives_upd
48/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Side Antihypertensive Agents: Side
EffectsEffectsVasodilatorsVasodilators
Hydralazine:Hydralazine:
dizziness, headache, anxiety, tachycardia,dizziness, headache, anxiety, tachycardia,nausea and vomiting, diarrhea, anemia,nausea and vomiting, diarrhea, anemia,dyspnea, edema, nasal congestiondyspnea, edema, nasal congestion
Sodium nitroprusside:Sodium nitroprusside:
bradycardia, hypotension, possiblebradycardia, hypotension, possiblecyanide toxicitycyanide toxicity
-
8/8/2019 Antihypertensives_upd
49/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Nursing ImplicationsNursing ImplicationsBefore beginning therapy, obtain a thoroughBefore beginning therapy, obtain a thoroughhealth history and headhealth history and head- -toto--toe physicaltoe physicalexamination.examination.
Assess for contraindications to specific Assess for contraindications to specificantihypertensive agents.antihypertensive agents.
Assess for conditions that require cautious Assess for conditions that require cautioususe of these agents.use of these agents.
-
8/8/2019 Antihypertensives_upd
50/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Nursing ImplicationsNursing ImplicationsEducate patients about the importance of notEducate patients about the importance of notmissing a dose and taking the medications exactlymissing a dose and taking the medications exactlyas prescribed.as prescribed.
Patients should never double up on doses if a dosePatients should never double up on doses if a doseis missed; check with physician for instructions onis missed; check with physician for instructions onwhat to do if a dose is missed.what to do if a dose is missed.
Monitor BP during therapy. Instruct patients toMonitor BP during therapy. Instruct patients tokeep a journal of regular BP checks.keep a journal of regular BP checks.
-
8/8/2019 Antihypertensives_upd
51/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Nursing ImplicationsNursing ImplicationsInstruct patients that these drugs should not beInstruct patients that these drugs should not bestopped abruptly, as this may cause a reboundstopped abruptly, as this may cause a reboundhypertensive crisis, and perhaps lead to CVA.hypertensive crisis, and perhaps lead to CVA.
Oral forms should be given with meals so thatOral forms should be given with meals so thatabsorption is more gradual and effective.absorption is more gradual and effective.
Administer IV forms with extreme caution and Administer IV forms with extreme caution anduse an IV pump.use an IV pump.
-
8/8/2019 Antihypertensives_upd
52/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Nursing ImplicationsNursing ImplicationsRemind patients that medications is only part of Remind patients that medications is only part of therapy. Encourage patients to watch their diet,therapy. Encourage patients to watch their diet,stress level, weight, and alcohol intake.stress level, weight, and alcohol intake.
Patients should avoid smoking and eating foodsPatients should avoid smoking and eating foodshigh in sodium.high in sodium.
Encourage supervised exercise.Encourage supervised exercise.
-
8/8/2019 Antihypertensives_upd
53/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Nursing ImplicationsNursing ImplicationsInstruct patients to change positions slowly to avoidInstruct patients to change positions slowly to avoidsyncope from postural hypotension.syncope from postural hypotension.
Patients should report unusual shortness of breath;Patients should report unusual shortness of breath;difficulty breathing; swelling of the feet, ankles, face,difficulty breathing; swelling of the feet, ankles, face,or around the eyes; weight gain or loss; chest pain;or around the eyes; weight gain or loss; chest pain;palpitations; or excessive fatigue.palpitations; or excessive fatigue.
-
8/8/2019 Antihypertensives_upd
54/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Nursing ImplicationsNursing ImplicationsMen taking these agents may not be aware thatMen taking these agents may not be aware thatimpotence is an expected effect. This may influenceimpotence is an expected effect. This may influencecompliance with drug therapy.compliance with drug therapy.
If patients are experiencing serious side effects,If patients are experiencing serious side effects,or believe that the dose or medication needs toor believe that the dose or medication needs tobe changed, they should contact their physicianbe changed, they should contact their physicianimmediately.immediately.
-
8/8/2019 Antihypertensives_upd
55/56
Copyright 2002, 1998, Elsevier Science (USA). All rights reserved.
Antihypertensive Agents: Antihypertensive Agents:
Nursing ImplicationsNursing ImplicationsHot tubs, showers, or baths; hot weather; prolongedHot tubs, showers, or baths; hot weather; prolongedsitting or standing; physical exercise; and alcoholsitting or standing; physical exercise; and alcoholingestion may aggravate low blood pressure,ingestion may aggravate low blood pressure,
leading to fainting and injury. Patients shouldleading to fainting and injury. Patients shouldsit or lie down until symptoms subside.sit or lie down until symptoms subside.
Patients should not take any other medications,Patients should not take any other medications,including OTC drugs, without first getting theincluding OTC drugs, without first getting theapproval of their physician.approval of their physician.
-
8/8/2019 Antihypertensives_upd
56/56
C i h 2002 1998 El i S i (USA) All i h d
Antihypertensive Agents: Antihypertensive Agents:
Nursing ImplicationsNursing ImplicationsMonitor for side/adverse effectsMonitor for side/adverse effects(dizziness, orthostatic hypotension, fatigue)(dizziness, orthostatic hypotension, fatigue)and for toxic effects.and for toxic effects.
Monitor for therapeutic effectsMonitor for therapeutic effects
Blood pressure should be maintained at lessBlood pressure should be maintained at lessthan 140/90 mm Hgthan 140/90 mm Hg